MEPHISTO (Macrophage Phenotype In Metabolic Syndrome With Iron Overload)
Condition(s):Dysmetabolic Iron Overload Syndrome; Metabolic Syndrome XLast Updated:February 19, 2014Unknown status
Hide Studies Not Open or Pending
Condition(s):Dysmetabolic Iron Overload Syndrome; Metabolic Syndrome XLast Updated:February 19, 2014Unknown status
Condition(s):Rare Iron Overloads Except C282Y HomozygosityLast Updated:March 10, 2015Terminated
Condition(s):Chronic Iron OverloadLast Updated:October 21, 2022Completed
Condition(s):Acute Lymphocytic Leukemia; Acute Myeloid LeukemiaLast Updated:May 16, 2017Completed
Condition(s):Iron OverloadLast Updated:April 11, 2018Completed
Condition(s):Sickle Cell Disease; Thalassemia; Marrow AplasiaLast Updated:September 18, 2019Completed
Condition(s):Thalassemia, Non-transfusional-dependent Thalassemia (NTDT), Myeloplastic Dysplasia (MDS), Other AnemiaLast Updated:April 12, 2017Completed
Condition(s):Platelet Changes in Cases of Iron OverloadLast Updated:April 1, 2020Unknown status
Condition(s):Platelet Changes in Cases of Iron OverloadLast Updated:April 1, 2020Unknown status
Condition(s):Cancer; Hematopoietic Stem Cell Transplantation; Allogeneic Hematopoietic Cell TransplantationLast Updated:December 2, 2017Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.